Percent Weight Change in the Medical Supplement Group of Early Breast Cancer
Conditions: Early Stage Breast Cancer Interventions: Dietary Supplement: Ensure Sponsors: Rajavithi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Contrast-Enhanced Spectral Mammography (CESM)
Conditions: Breast Cancer Interventions: Device: Contrast Enhanced Mammography Sponsors: European Institute of Oncology Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Conditions: Breast Neoplasms Interventions: Drug: MK-2870; Biological: Pembrolizumab; Drug: Paclitaxel; Drug: Nab-paclitaxel; Drug: Capecitabine; Drug: Liposomal doxorubicin Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients
Conditions: Breast Cancer Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Radiotherapy for Breast Cancer
Conditions: Neoadjuvant Radiotherapy; Breast Cancer Interventions: Radiation: Neoadjuvant radiotherapy; Radiation: adjuvant radiotherapy Sponsors: Changhai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Decision Impact Study of PreciseDx Breast
Conditions: Breast Cancer Interventions: Other: Standard of Care Sponsors: Precise Dx, Inc.; The Cleveland Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy
Conditions: Prehabilitation; Breast Cancer; Postmenopause; Resistance Training Interventions: Other: Prehabilitation with resistance-exercise training Sponsors: Universidad de La Frontera Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
Conditions: Metastatic Breast Cancer Interventions: Drug: Eribulin; Drug: Sintilimab Sponsors: Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma
Conditions: Triple Negative Breast Cancer; Carbonic Anhydrase IX Interventions: Diagnostic Test: Carbonic anhydrase staining levels Sponsors: Kahramanmaras Sutcu Imam University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment
Conditions: Breast Cancer Interventions: Behavioral: eHealth self-management support program; Behavioral: Face-to-face rehabilitation program Sponsors: Universiteit Antwerpen; Universitaire Ziekenhuizen KU Leuven; University Ghent; KU Leuven; University Hospital, Antwerp Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Nurse-led Mind-body Intervention on Sexual Health for Breast Cancer Survivors
Conditions: Women ' s Health: Neoplasm of Breast; Menopause, Premature; Body Image; Sexual Dysfunction; Cancer, Breast Interventions: Behavioral: Intimate Pathways Intervention Sponsors: University of Arkansas; Intimate Pathways, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Real-world Study of Inetetamab in HER2-positive Metastatic Breast Cancer
Conditions: HER2-positive Metastatic Breast Cancer Interventions: Drug: inetetamab Sponsors: Liaoning Tumor Hospital& Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Conditions: Cancer; Solid Tumor; Colorectal Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Targeted Therapy; Chemotherapy; Immunotherapy; Precision Therapy Interventions: Genetic: SNP; Drug: Palbociclib 125mg; Drug: Bevacizumab Sponsors: Lebanese University; Haykel Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Topical Tacrolimus for Breast Cancer-related Lymphedema
Conditions: Lymphedema Interventions: Drug: Tacrolimus; Drug: Placebo Sponsors: Odense University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
Conditions: Breast Cancer Interventions: Drug: Palbociclib in combination with AI Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
